Executive summary. Diagnosis, treatment and prophylaxis of influenza virus infection. Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

López‐Medrano, Francisco; Alfayate, Santiago; Carratalà, Jordi; Chamorro-Camazón, Judith; Cordero, Elisa; Cruz-Cañete, Marta; Fernández-Prada, María; García-Cenoz, Manuel; Marcos, María Ángeles; Melón, Santiago; Moreno-Millán, Nemesio; García, María Dolorès Vivero; Lejarazu, Raúl Ortíz de; Pérez‐Martín, Jaime Jesús; Rodríguez‐García, Juan; Schwarz‐Chavarri, Germán; Tagarro-García, Alfredo; Esso-Arbolave, Diego van; Viasus, Diego; Pumarola, Tomás

doi:10.1016/j.eimc.2022.10.010

Cited by 6 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, in the hospital setting, at the current cost, all admitted patients should have mIVD testing, especially those on oxygen therapy either in or out of the ICU, the immunocompromised, and those with underlying comorbidities. There was agreement that patients with RTI to be IVD tested should be the same as those considered in the Influenza Consensus document [ 1 ]. Similarly, critically ill and immunocompromised patients in the Emergency Unit should have an mIVD test upon arrival.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The role of viral diagnostic tests in respiratory tract infections: moving forward

Ortíz de Lejarazu,

Eiros,

López-Medrano

et al. 2024

Rev Esp Quimioter

Self Cite

View full text Add to dashboard Cite

The increased knowledge on virology and the increased potential of their diagnostic has risen several relevant question about the role of an early viral diagnosis and potential early treatment on the management of respiratory tract infections (RTI). In order to further understand the role of viral diagnostic tests in the management of RTI, a panel of experts was convened to discuss about their potential role, beyond what had been agreed in Influenza. The objective of this panel was to define the plausible role of aetiologic viral diagnostic into clinical management; make recommendations on the potential expanded use of such tests in the future and define some gaps in the management of RTI. Molecular Infection Viral Diagnostic (mIVD) tests should be used in all adult patients admitted to Hospital with RTI, and in paediatric patients requiring admission or who would be referred to another hospital for more specialised care. The increased use of mIVD will not only reduce the inappropriate use of antibiotics so reducing the antibiotic microbe resistance, but also will improve the outcome of the patient if an aetiologic viral therapy can be warranted, saving resource requirements and improving patient flows. Implementing IVD testing in RTI has various organizational benefits as well, but expanding its use into clinical settings would need a cost-effectiveness strategy and budget impact assessment.

show abstract

Section: Resultsmentioning

confidence: 99%

“…In February 2023 a consensus on the management of Influenza was published [ 1 ]. After the COVID pandemic this helped to raise the awareness on the potential benefits of an accurate management of viral infections [ 2 ].…”

Section: Introductionmentioning

confidence: 99%